Global Osteoarthritis Medications Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Osteoarthritis Medications Market Size 2017-2028

2.1.2 Osteoarthritis Medications Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Osteoarthritis Medications Segment by Type

2.2.1 NSAIDs

2.2.2 Corticosteroids

2.2.3 Hyaluronic Acid Injection

2.2.4 Others

2.3 Osteoarthritis Medications Market Size by Type

2.3.1 Osteoarthritis Medications Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Osteoarthritis Medications Market Size Market Share by Type (2017-2022)

2.4 Osteoarthritis Medications Segment by Application

2.4.1 Hospital Pharmacies

2.4.2 Retail Pharmacies

2.4.3 Online Pharmacies

2.5 Osteoarthritis Medications Market Size by Application

2.5.1 Osteoarthritis Medications Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Osteoarthritis Medications Market Size Market Share by Application (2017-2022)

3 Osteoarthritis Medications Market Size by Player

3.1 Osteoarthritis Medications Market Size Market Share by Players

3.1.1 Global Osteoarthritis Medications Revenue by Players (2020-2022)

3.1.2 Global Osteoarthritis Medications Revenue Market Share by Players (2020-2022)

3.2 Global Osteoarthritis Medications Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Osteoarthritis Medications by Regions

4.1 Osteoarthritis Medications Market Size by Regions (2017-2022)

4.2 Americas Osteoarthritis Medications Market Size Growth (2017-2022)

4.3 APAC Osteoarthritis Medications Market Size Growth (2017-2022)

4.4 Europe Osteoarthritis Medications Market Size Growth (2017-2022)

4.5 Middle East & Africa Osteoarthritis Medications Market Size Growth (2017-2022)

5 Americas

5.1 Americas Osteoarthritis Medications Market Size by Country (2017-2022)

5.2 Americas Osteoarthritis Medications Market Size by Type (2017-2022)

5.3 Americas Osteoarthritis Medications Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Osteoarthritis Medications Market Size by Region (2017-2022)

6.2 APAC Osteoarthritis Medications Market Size by Type (2017-2022)

6.3 APAC Osteoarthritis Medications Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Osteoarthritis Medications by Country (2017-2022)

7.2 Europe Osteoarthritis Medications Market Size by Type (2017-2022)

7.3 Europe Osteoarthritis Medications Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Osteoarthritis Medications by Region (2017-2022)

8.2 Middle East & Africa Osteoarthritis Medications Market Size by Type (2017-2022)

8.3 Middle East & Africa Osteoarthritis Medications Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Osteoarthritis Medications Market Forecast

10.1 Global Osteoarthritis Medications Forecast by Regions (2023-2028)

10.1.1 Global Osteoarthritis Medications Forecast by Regions (2023-2028)

10.1.2 Americas Osteoarthritis Medications Forecast

10.1.3 APAC Osteoarthritis Medications Forecast

10.1.4 Europe Osteoarthritis Medications Forecast

10.1.5 Middle East & Africa Osteoarthritis Medications Forecast

10.2 Americas Osteoarthritis Medications Forecast by Country (2023-2028)

10.2.1 United States Osteoarthritis Medications Market Forecast

10.2.2 Canada Osteoarthritis Medications Market Forecast

10.2.3 Mexico Osteoarthritis Medications Market Forecast

10.2.4 Brazil Osteoarthritis Medications Market Forecast

10.3 APAC Osteoarthritis Medications Forecast by Region (2023-2028)

10.3.1 China Osteoarthritis Medications Market Forecast

10.3.2 Japan Osteoarthritis Medications Market Forecast

10.3.3 Korea Osteoarthritis Medications Market Forecast

10.3.4 Southeast Asia Osteoarthritis Medications Market Forecast

10.3.5 India Osteoarthritis Medications Market Forecast

10.3.6 Australia Osteoarthritis Medications Market Forecast

10.4 Europe Osteoarthritis Medications Forecast by Country (2023-2028)

10.4.1 Germany Osteoarthritis Medications Market Forecast

10.4.2 France Osteoarthritis Medications Market Forecast

10.4.3 UK Osteoarthritis Medications Market Forecast

10.4.4 Italy Osteoarthritis Medications Market Forecast

10.4.5 Russia Osteoarthritis Medications Market Forecast

10.5 Middle East & Africa Osteoarthritis Medications Forecast by Region (2023-2028)

10.5.1 Egypt Osteoarthritis Medications Market Forecast

10.5.2 South Africa Osteoarthritis Medications Market Forecast

10.5.3 Israel Osteoarthritis Medications Market Forecast

10.5.4 Turkey Osteoarthritis Medications Market Forecast

10.5.5 GCC Countries Osteoarthritis Medications Market Forecast

10.6 Global Osteoarthritis Medications Forecast by Type (2023-2028)

10.7 Global Osteoarthritis Medications Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Pfizer

11.1.1 Pfizer Company Information

11.1.2 Pfizer Osteoarthritis Medications Product Offered

11.1.3 Pfizer Osteoarthritis Medications Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Pfizer Main Business Overview

11.1.5 Pfizer Latest Developments

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Information

11.2.2 Johnson & Johnson Osteoarthritis Medications Product Offered

11.2.3 Johnson & Johnson Osteoarthritis Medications Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Johnson & Johnson Main Business Overview

11.2.5 Johnson & Johnson Latest Developments

11.3 GlaxoSmithKline

11.3.1 GlaxoSmithKline Company Information

11.3.2 GlaxoSmithKline Osteoarthritis Medications Product Offered

11.3.3 GlaxoSmithKline Osteoarthritis Medications Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 GlaxoSmithKline Main Business Overview

11.3.5 GlaxoSmithKline Latest Developments

11.4 Novartis

11.4.1 Novartis Company Information

11.4.2 Novartis Osteoarthritis Medications Product Offered

11.4.3 Novartis Osteoarthritis Medications Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Novartis Main Business Overview

11.4.5 Novartis Latest Developments

11.5 Bayer

11.5.1 Bayer Company Information

11.5.2 Bayer Osteoarthritis Medications Product Offered

11.5.3 Bayer Osteoarthritis Medications Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Bayer Main Business Overview

11.5.5 Bayer Latest Developments

11.6 Eli Lilly

11.6.1 Eli Lilly Company Information

11.6.2 Eli Lilly Osteoarthritis Medications Product Offered

11.6.3 Eli Lilly Osteoarthritis Medications Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Eli Lilly Main Business Overview

11.6.5 Eli Lilly Latest Developments

11.7 Sanofi

11.7.1 Sanofi Company Information

11.7.2 Sanofi Osteoarthritis Medications Product Offered

11.7.3 Sanofi Osteoarthritis Medications Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Sanofi Main Business Overview

11.7.5 Sanofi Latest Developments

11.8 Horizon Pharma

11.8.1 Horizon Pharma Company Information

11.8.2 Horizon Pharma Osteoarthritis Medications Product Offered

11.8.3 Horizon Pharma Osteoarthritis Medications Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Horizon Pharma Main Business Overview

11.8.5 Horizon Pharma Latest Developments

11.9 Abbott

11.9.1 Abbott Company Information

11.9.2 Abbott Osteoarthritis Medications Product Offered

11.9.3 Abbott Osteoarthritis Medications Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Abbott Main Business Overview

11.9.5 Abbott Latest Developments

11.10 Mylan

11.10.1 Mylan Company Information

11.10.2 Mylan Osteoarthritis Medications Product Offered

11.10.3 Mylan Osteoarthritis Medications Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Mylan Main Business Overview

11.10.5 Mylan Latest Developments

11.11 Daiichi Sankyo

11.11.1 Daiichi Sankyo Company Information

11.11.2 Daiichi Sankyo Osteoarthritis Medications Product Offered

11.11.3 Daiichi Sankyo Osteoarthritis Medications Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Daiichi Sankyo Main Business Overview

11.11.5 Daiichi Sankyo Latest Developments

11.12 TEVA

11.12.1 TEVA Company Information

11.12.2 TEVA Osteoarthritis Medications Product Offered

11.12.3 TEVA Osteoarthritis Medications Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 TEVA Main Business Overview

11.12.5 TEVA Latest Developments

11.13 Almatica Pharma

11.13.1 Almatica Pharma Company Information

11.13.2 Almatica Pharma Osteoarthritis Medications Product Offered

11.13.3 Almatica Pharma Osteoarthritis Medications Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Almatica Pharma Main Business Overview

11.13.5 Almatica Pharma Latest Developments

11.14 Astellas Pharma

11.14.1 Astellas Pharma Company Information

11.14.2 Astellas Pharma Osteoarthritis Medications Product Offered

11.14.3 Astellas Pharma Osteoarthritis Medications Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Astellas Pharma Main Business Overview

11.14.5 Astellas Pharma Latest Developments

11.15 Tide Pharmaceutical

11.15.1 Tide Pharmaceutical Company Information

11.15.2 Tide Pharmaceutical Osteoarthritis Medications Product Offered

11.15.3 Tide Pharmaceutical Osteoarthritis Medications Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Tide Pharmaceutical Main Business Overview

11.15.5 Tide Pharmaceutical Latest Developments

11.16 Iroko Pharmaceuticals

11.16.1 Iroko Pharmaceuticals Company Information

11.16.2 Iroko Pharmaceuticals Osteoarthritis Medications Product Offered

11.16.3 Iroko Pharmaceuticals Osteoarthritis Medications Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Iroko Pharmaceuticals Main Business Overview

11.16.5 Iroko Pharmaceuticals Latest Developments

11.17 Hengrui Pharmaceutical

11.17.1 Hengrui Pharmaceutical Company Information

11.17.2 Hengrui Pharmaceutical Osteoarthritis Medications Product Offered

11.17.3 Hengrui Pharmaceutical Osteoarthritis Medications Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Hengrui Pharmaceutical Main Business Overview

11.17.5 Hengrui Pharmaceutical Latest Developments

11.18 Abiogen Pharma

11.18.1 Abiogen Pharma Company Information

11.18.2 Abiogen Pharma Osteoarthritis Medications Product Offered

11.18.3 Abiogen Pharma Osteoarthritis Medications Revenue, Gross Margin and Market Share (2020-2022)

11.18.4 Abiogen Pharma Main Business Overview

11.18.5 Abiogen Pharma Latest Developments

11.19 Flexion Therapeutics

11.19.1 Flexion Therapeutics Company Information

11.19.2 Flexion Therapeutics Osteoarthritis Medications Product Offered

11.19.3 Flexion Therapeutics Osteoarthritis Medications Revenue, Gross Margin and Market Share (2020-2022)

11.19.4 Flexion Therapeutics Main Business Overview

11.19.5 Flexion Therapeutics Latest Developments

11.20 Anika Therapeutics

11.20.1 Anika Therapeutics Company Information

11.20.2 Anika Therapeutics Osteoarthritis Medications Product Offered

11.20.3 Anika Therapeutics Osteoarthritis Medications Revenue, Gross Margin and Market Share (2020-2022)

11.20.4 Anika Therapeutics Main Business Overview

11.20.5 Anika Therapeutics Latest Developments

12 Research Findings and Conclusion

Table 1. Osteoarthritis Medications Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of NSAIDs

Table 3. Major Players of Corticosteroids

Table 4. Major Players of Hyaluronic Acid Injection

Table 5. Major Players of Others

Table 6. Osteoarthritis Medications Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 7. Global Osteoarthritis Medications Market Size by Type (2017-2022) & ($ Millions)

Table 8. Global Osteoarthritis Medications Market Size Market Share by Type (2017-2022)

Table 9. Osteoarthritis Medications Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Osteoarthritis Medications Market Size by Application (2017-2022) & ($ Millions)

Table 11. Global Osteoarthritis Medications Market Size Market Share by Application (2017-2022)

Table 12. Global Osteoarthritis Medications Revenue by Players (2020-2022) & ($ Millions)

Table 13. Global Osteoarthritis Medications Revenue Market Share by Player (2020-2022)

Table 14. Osteoarthritis Medications Key Players Head office and Products Offered

Table 15. Osteoarthritis Medications Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Osteoarthritis Medications Market Size by Regions 2017-2022 & ($ Millions)

Table 19. Global Osteoarthritis Medications Market Size Market Share by Regions (2017-2022)

Table 20. Americas Osteoarthritis Medications Market Size by Country (2017-2022) & ($ Millions)

Table 21. Americas Osteoarthritis Medications Market Size Market Share by Country (2017-2022)

Table 22. Americas Osteoarthritis Medications Market Size by Type (2017-2022) & ($ Millions)

Table 23. Americas Osteoarthritis Medications Market Size Market Share by Type (2017-2022)

Table 24. Americas Osteoarthritis Medications Market Size by Application (2017-2022) & ($ Millions)

Table 25. Americas Osteoarthritis Medications Market Size Market Share by Application (2017-2022)

Table 26. APAC Osteoarthritis Medications Market Size by Region (2017-2022) & ($ Millions)

Table 27. APAC Osteoarthritis Medications Market Size Market Share by Region (2017-2022)

Table 28. APAC Osteoarthritis Medications Market Size by Type (2017-2022) & ($ Millions)

Table 29. APAC Osteoarthritis Medications Market Size Market Share by Type (2017-2022)

Table 30. APAC Osteoarthritis Medications Market Size by Application (2017-2022) & ($ Millions)

Table 31. APAC Osteoarthritis Medications Market Size Market Share by Application (2017-2022)

Table 32. Europe Osteoarthritis Medications Market Size by Country (2017-2022) & ($ Millions)

Table 33. Europe Osteoarthritis Medications Market Size Market Share by Country (2017-2022)

Table 34. Europe Osteoarthritis Medications Market Size by Type (2017-2022) & ($ Millions)

Table 35. Europe Osteoarthritis Medications Market Size Market Share by Type (2017-2022)

Table 36. Europe Osteoarthritis Medications Market Size by Application (2017-2022) & ($ Millions)

Table 37. Europe Osteoarthritis Medications Market Size Market Share by Application (2017-2022)

Table 38. Middle East & Africa Osteoarthritis Medications Market Size by Region (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Osteoarthritis Medications Market Size Market Share by Region (2017-2022)

Table 40. Middle East & Africa Osteoarthritis Medications Market Size by Type (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Osteoarthritis Medications Market Size Market Share by Type (2017-2022)

Table 42. Middle East & Africa Osteoarthritis Medications Market Size by Application (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Osteoarthritis Medications Market Size Market Share by Application (2017-2022)

Table 44. Key Market Drivers & Growth Opportunities of Osteoarthritis Medications

Table 45. Key Market Challenges & Risks of Osteoarthritis Medications

Table 46. Key Industry Trends of Osteoarthritis Medications

Table 47. Global Osteoarthritis Medications Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 48. Global Osteoarthritis Medications Market Size Market Share Forecast by Regions (2023-2028)

Table 49. Global Osteoarthritis Medications Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 50. Global Osteoarthritis Medications Market Size Market Share Forecast by Type (2023-2028)

Table 51. Global Osteoarthritis Medications Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 52. Global Osteoarthritis Medications Market Size Market Share Forecast by Application (2023-2028)

Table 53. Pfizer Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors

Table 54. Pfizer Osteoarthritis Medications Product Offered

Table 55. Pfizer Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 56. Pfizer Main Business

Table 57. Pfizer Latest Developments

Table 58. Johnson & Johnson Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors

Table 59. Johnson & Johnson Osteoarthritis Medications Product Offered

Table 60. Johnson & Johnson Main Business

Table 61. Johnson & Johnson Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. Johnson & Johnson Latest Developments

Table 63. GlaxoSmithKline Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors

Table 64. GlaxoSmithKline Osteoarthritis Medications Product Offered

Table 65. GlaxoSmithKline Main Business

Table 66. GlaxoSmithKline Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 67. GlaxoSmithKline Latest Developments

Table 68. Novartis Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors

Table 69. Novartis Osteoarthritis Medications Product Offered

Table 70. Novartis Main Business

Table 71. Novartis Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 72. Novartis Latest Developments

Table 73. Bayer Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors

Table 74. Bayer Osteoarthritis Medications Product Offered

Table 75. Bayer Main Business

Table 76. Bayer Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 77. Bayer Latest Developments

Table 78. Eli Lilly Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors

Table 79. Eli Lilly Osteoarthritis Medications Product Offered

Table 80. Eli Lilly Main Business

Table 81. Eli Lilly Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 82. Eli Lilly Latest Developments

Table 83. Sanofi Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors

Table 84. Sanofi Osteoarthritis Medications Product Offered

Table 85. Sanofi Main Business

Table 86. Sanofi Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 87. Sanofi Latest Developments

Table 88. Horizon Pharma Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors

Table 89. Horizon Pharma Osteoarthritis Medications Product Offered

Table 90. Horizon Pharma Main Business

Table 91. Horizon Pharma Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 92. Horizon Pharma Latest Developments

Table 93. Abbott Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors

Table 94. Abbott Osteoarthritis Medications Product Offered

Table 95. Abbott Main Business

Table 96. Abbott Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 97. Abbott Latest Developments

Table 98. Mylan Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors

Table 99. Mylan Osteoarthritis Medications Product Offered

Table 100. Mylan Main Business

Table 101. Mylan Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 102. Mylan Latest Developments

Table 103. Daiichi Sankyo Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors

Table 104. Daiichi Sankyo Osteoarthritis Medications Product Offered

Table 105. Daiichi Sankyo Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 106. Daiichi Sankyo Main Business

Table 107. Daiichi Sankyo Latest Developments

Table 108. TEVA Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors

Table 109. TEVA Osteoarthritis Medications Product Offered

Table 110. TEVA Main Business

Table 111. TEVA Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 112. TEVA Latest Developments

Table 113. Almatica Pharma Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors

Table 114. Almatica Pharma Osteoarthritis Medications Product Offered

Table 115. Almatica Pharma Main Business

Table 116. Almatica Pharma Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 117. Almatica Pharma Latest Developments

Table 118. Astellas Pharma Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors

Table 119. Astellas Pharma Osteoarthritis Medications Product Offered

Table 120. Astellas Pharma Main Business

Table 121. Astellas Pharma Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 122. Astellas Pharma Latest Developments

Table 123. Tide Pharmaceutical Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors

Table 124. Tide Pharmaceutical Osteoarthritis Medications Product Offered

Table 125. Tide Pharmaceutical Main Business

Table 126. Tide Pharmaceutical Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 127. Tide Pharmaceutical Latest Developments

Table 128. Iroko Pharmaceuticals Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors

Table 129. Iroko Pharmaceuticals Osteoarthritis Medications Product Offered

Table 130. Iroko Pharmaceuticals Main Business

Table 131. Iroko Pharmaceuticals Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 132. Iroko Pharmaceuticals Latest Developments

Table 133. Hengrui Pharmaceutical Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors

Table 134. Hengrui Pharmaceutical Osteoarthritis Medications Product Offered

Table 135. Hengrui Pharmaceutical Main Business

Table 136. Hengrui Pharmaceutical Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 137. Hengrui Pharmaceutical Latest Developments

Table 138. Abiogen Pharma Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors

Table 139. Abiogen Pharma Osteoarthritis Medications Product Offered

Table 140. Abiogen Pharma Main Business

Table 141. Abiogen Pharma Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 142. Abiogen Pharma Latest Developments

Table 143. Flexion Therapeutics Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors

Table 144. Flexion Therapeutics Osteoarthritis Medications Product Offered

Table 145. Flexion Therapeutics Main Business

Table 146. Flexion Therapeutics Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 147. Flexion Therapeutics Latest Developments

Table 148. Anika Therapeutics Details, Company Type, Osteoarthritis Medications Area Served and Its Competitors

Table 149. Anika Therapeutics Osteoarthritis Medications Product Offered

Table 150. Anika Therapeutics Main Business

Table 151. Anika Therapeutics Osteoarthritis Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 152. Anika Therapeutics Latest Developments

List of Figures

Figure 1. Osteoarthritis Medications Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Osteoarthritis Medications Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Osteoarthritis Medications Market Size Market Share by Type in 2021

Figure 7. Osteoarthritis Medications in Hospital Pharmacies

Figure 8. Global Osteoarthritis Medications Market: Hospital Pharmacies (2017-2022) & ($ Millions)

Figure 9. Osteoarthritis Medications in Retail Pharmacies

Figure 10. Global Osteoarthritis Medications Market: Retail Pharmacies (2017-2022) & ($ Millions)

Figure 11. Osteoarthritis Medications in Online Pharmacies

Figure 12. Global Osteoarthritis Medications Market: Online Pharmacies (2017-2022) & ($ Millions)

Figure 13. Global Osteoarthritis Medications Market Size Market Share by Application in 2021

Figure 14. Global Osteoarthritis Medications Revenue Market Share by Player in 2021

Figure 15. Global Osteoarthritis Medications Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Osteoarthritis Medications Market Size 2017-2022 ($ Millions)

Figure 17. APAC Osteoarthritis Medications Market Size 2017-2022 ($ Millions)

Figure 18. Europe Osteoarthritis Medications Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Osteoarthritis Medications Market Size 2017-2022 ($ Millions)

Figure 20. Americas Osteoarthritis Medications Value Market Share by Country in 2021

Figure 21. Americas Osteoarthritis Medications Consumption Market Share by Type in 2021

Figure 22. Americas Osteoarthritis Medications Market Size Market Share by Application in 2021

Figure 23. United States Osteoarthritis Medications Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Osteoarthritis Medications Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Osteoarthritis Medications Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Osteoarthritis Medications Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Osteoarthritis Medications Market Size Market Share by Region in 2021

Figure 28. APAC Osteoarthritis Medications Market Size Market Share by Application in 2021

Figure 29. China Osteoarthritis Medications Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Osteoarthritis Medications Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Osteoarthritis Medications Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Osteoarthritis Medications Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Osteoarthritis Medications Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Osteoarthritis Medications Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Osteoarthritis Medications Market Size Market Share by Country in 2021

Figure 36. Europe Osteoarthritis Medications Market Size Market Share by Type in 2021

Figure 37. Europe Osteoarthritis Medications Market Size Market Share by Application in 2021

Figure 38. Germany Osteoarthritis Medications Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Osteoarthritis Medications Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Osteoarthritis Medications Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Osteoarthritis Medications Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Osteoarthritis Medications Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Osteoarthritis Medications Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Osteoarthritis Medications Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Osteoarthritis Medications Market Size Market Share by Application in 2021

Figure 46. Egypt Osteoarthritis Medications Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Osteoarthritis Medications Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Osteoarthritis Medications Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Osteoarthritis Medications Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Osteoarthritis Medications Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Osteoarthritis Medications Market Size 2023-2028 ($ Millions)

Figure 52. APAC Osteoarthritis Medications Market Size 2023-2028 ($ Millions)

Figure 53. Europe Osteoarthritis Medications Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Osteoarthritis Medications Market Size 2023-2028 ($ Millions)

Figure 55. United States Osteoarthritis Medications Market Size 2023-2028 ($ Millions)

Figure 56. Canada Osteoarthritis Medications Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Osteoarthritis Medications Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Osteoarthritis Medications Market Size 2023-2028 ($ Millions)

Figure 59. China Osteoarthritis Medications Market Size 2023-2028 ($ Millions)

Figure 60. Japan Osteoarthritis Medications Market Size 2023-2028 ($ Millions)

Figure 61. Korea Osteoarthritis Medications Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Osteoarthritis Medications Market Size 2023-2028 ($ Millions)

Figure 63. India Osteoarthritis Medications Market Size 2023-2028 ($ Millions)

Figure 64. Australia Osteoarthritis Medications Market Size 2023-2028 ($ Millions)

Figure 65. Germany Osteoarthritis Medications Market Size 2023-2028 ($ Millions)

Figure 66. France Osteoarthritis Medications Market Size 2023-2028 ($ Millions)

Figure 67. UK Osteoarthritis Medications Market Size 2023-2028 ($ Millions)

Figure 68. Italy Osteoarthritis Medications Market Size 2023-2028 ($ Millions)

Figure 69. Russia Osteoarthritis Medications Market Size 2023-2028 ($ Millions)

Figure 70. Spain Osteoarthritis Medications Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Osteoarthritis Medications Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Osteoarthritis Medications Market Size 2023-2028 ($ Millions)

Figure 73. Israel Osteoarthritis Medications Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Osteoarthritis Medications Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Osteoarthritis Medications Market Size 2023-2028 ($ Millions)